Rheumatoid nodules are firm, rubbery lumps that form under the skin and sometimes inside organs in people with rheumatoid arthritis (RA). They are the most common extra-articular feature of the disease, meaning they are the most frequent sign of RA that occurs outside the joints themselves. These nodules tend to develop in people with more aggressive, seropositive disease, and their presence carries implications that go well beyond cosmetic concern.
Who Develops Rheumatoid Nodules
Not everyone with RA gets nodules. They appear far more often in people whose blood tests are positive for rheumatoid factor (RF) and anti-CCP antibodies, the two key markers of seropositive disease. A study of cutaneous manifestations in RA found that nodules occurred significantly more frequently in patients with longstanding disease, positive RF and anti-CCP results, and those taking certain medications including TNF-alpha antagonists and leflunomide.1PubMed. Incidence and classification of cutaneous manifestations in rheumatoid arthritis Separate research confirmed the link between nodules and all three major autoantibodies: RF, anti-CCP, and anti-MCV.2PubMed Central. Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis
Smoking is another strong risk factor, and the numbers are striking. A study of early RA found that having ever smoked raised the odds of developing rheumatoid nodules roughly sevenfold. Interestingly, the risk did not appear to be clearly dose-dependent when researchers looked at how long or how much a person had smoked. The connection only held in people who were also RF-positive, suggesting that smoking and autoantibody status reinforce each other in driving nodule formation.3BMJ Journals. Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis
Given these links, you might expect genetics to play a large role, particularly the HLA-DRB1 “shared epitope” alleles that are strongly tied to RA susceptibility overall. But a meta-analysis of over 3,200 Caucasian RA patients found that the shared epitope did not significantly increase the risk of nodules. Only one specific allele, DRB1*0401, showed a weak association when inherited as a single copy. The researchers concluded that environmental and other factors likely matter more than the genetic variants most closely linked to RA itself.4PubMed. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis
What Is Happening Inside a Nodule
Under a microscope, a rheumatoid nodule has a distinctive layered structure: a dead, collagen-rich core surrounded by a ring of immune cells arranged in a palisading pattern, all enclosed in a zone of chronic inflammation.5PubMed Central. Rheumatoid nodule This is not just an inert lump of scar tissue. The immune environment inside a nodule closely mirrors what happens inside an inflamed joint. Macrophages in the nodule produce TNF-alpha and interleukin-1-beta, the same inflammatory signals that drive joint destruction. The cell adhesion molecules that allow immune cells to stick to blood vessel walls and infiltrate tissue are also shared between nodules and joint linings, with some subtle differences in expression.6Arthritis & Rheumatism. Pathogenic mechanisms in the rheumatoid nodule: Comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient
Detailed analysis of the cytokines present in nodules shows they behave as a particular type of immune reaction. Nine out of ten nodules tested contained interferon-gamma, and all ten contained TNF-alpha, IL-1-beta, IL-10, IL-15, and IL-18. By contrast, there was no evidence of IL-2, IL-4, or IL-5. This profile points to a Th1-driven granuloma, a pattern associated with cell-mediated immune responses rather than the allergic-type reactions driven by Th2 cells.7PubMed. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma In practical terms, the nodule is a miniature version of the same immune attack happening in the joints, just occurring in soft tissue instead.
Where Nodules Typically Appear
The classic location is over the back of the forearm, especially near the elbow, where repeated pressure from leaning on surfaces seems to play a role. They also show up over finger joints, Achilles tendons, the backs of the heels, and occasionally on the bridge of the nose or on the ears. Any area that experiences friction or mechanical stress is a candidate. The nodules are usually firm and moveable, ranging from a few millimeters to several centimeters, and they are often painless unless they press on a nerve or sit in a spot that catches on clothing or surfaces.
When nodules grow near a nerve, the consequences can be more than cosmetic. A case report documented a recurrently infected nodule in the forearm that eventually caused posterior interosseous nerve palsy, leading to an inability to extend the fingers and wrist properly.8PubMed Central. Recurrently Infected Rheumatoid Nodule Causing Posterior Interosseous Nerve Palsy: A Report of a Rare Case Situations like this are uncommon, but they underscore why nodules in certain locations warrant closer monitoring.
The Methotrexate Paradox
One of the more frustrating aspects of rheumatoid nodules is that methotrexate, the most commonly used disease-modifying drug for RA, can actually trigger new ones. This phenomenon, called accelerated nodulosis, was identified in a double-blind study that estimated its incidence at about 8% of methotrexate-treated patients. The new nodules were small and showed up predominantly on the fingers, a location not typical for standard rheumatoid nodules. Crucially, they had the same microscopic appearance as ordinary nodules and were not seen in patients on other treatments in the same study.9PubMed. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases
Methotrexate-induced nodulosis puts patients and doctors in an awkward position. The drug is effectively controlling joint inflammation while simultaneously producing a new extra-articular problem. In some cases, stopping methotrexate leads the nodules to shrink, but they can return if the drug is restarted. A review of management strategies found that adding hydroxychloroquine, colchicine, sulfasalazine, azathioprine, or D-penicillamine led to nodule regression in nearly all patients treated.10PubMed. A review of methotrexate-induced accelerated nodulosis Of these, hydroxychloroquine has the most practical appeal since it carries its own disease-modifying benefits and is often already part of a combination RA regimen.
Nodules in the Lungs
Rheumatoid nodules are not limited to the skin. They can form in the lungs, where they typically appear as multiple round masses on imaging. This creates a serious diagnostic challenge because pulmonary nodules are also one of the hallmark findings in lung cancer. A study comparing rheumatoid lung nodules with malignant ones on CT scans found several features that help distinguish them: rheumatoid nodules are more likely to be multiple, smooth-bordered, cavitated, located at the lung periphery, and accompanied by satellite nodules and a subpleural rind of soft tissue. When three or more of these features were present, the imaging achieved about 77% sensitivity and 92% specificity for correctly identifying a nodule as rheumatoid rather than cancerous. PET scans added another useful clue: rheumatoid nodules showed much lower metabolic activity than malignant ones and lacked the bright lymph nodes that typically light up around tumors.11PubMed. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy
A related condition called Caplan syndrome occurs when rheumatoid pulmonary nodules develop in people who have been exposed to inorganic dust, particularly coal dust. First described in the 1950s in coal miners with RA, it produces multiple well-defined rounded nodules throughout the lungs, often appearing in crops, sometimes cavitating or calcifying. The nodules are usually 0.5 to several centimeters in diameter and sit predominantly at the periphery of the lungs.12PubMed. Rheumatoid pneumoconiosis (Caplan’s syndrome) Although coal mining has declined in many countries, the syndrome remains diagnostically relevant. A recent case report documented a 41-year-old former miner who developed multiple cavitary pulmonary nodules years after leaving the mining sector, initially suspected to be cancer.13PubMed. Caplan syndrome in the 21st century: Cavitary nodules and delayed rheumatoid arthritis The delay between dust exposure and nodule development can be decades, which makes it easy to overlook occupational history when evaluating new lung findings.
Nodules in the Heart
Perhaps the most alarming location for rheumatoid nodules is the heart, though this is rare. Nodules can form on heart valves, in the heart muscle, and in the pericardium. A case involving all four cardiac valves along with the adjacent heart muscle and pericardium resulted in aortic and mitral valve leakage, heart failure, and conduction problems.14The American Journal of Medicine. Quadrivalvular rheumatoid heart disease associated with left bundle branch block In another documented case, a nodule disrupted the heart’s electrical conduction system and caused complete heart block.15PubMed Central. Rheumatoid heart disease with complete heart block These cases are extreme, and most people with rheumatoid nodules will never face cardiac involvement at this level. But they illustrate that the same immune process forming bumps under the elbow skin can, in theory, target nearly any tissue in the body.
Nodules as a Cardiovascular Warning Sign
Even when nodules are only present under the skin, their mere existence may signal elevated cardiovascular risk. A large US registry study found that RA patients with subcutaneous nodules at enrollment had higher rates of heart attacks, strokes, and cardiovascular death compared with RA patients who had no nodules. The unadjusted incidence rate ratios were roughly 1.5 to 1.7 across these outcomes. After adjusting for age, sex, and traditional cardiovascular risk factors, the association weakened but remained statistically significant, with a hazard ratio around 1.25 for composite cardiovascular events.16PubMed. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry After further adjustment for RA disease severity itself, the association lost statistical significance, suggesting that nodules serve as a marker of more severe disease rather than an independent cause of cardiovascular events. Still, for a patient or a clinician, the presence of nodules is a useful signal that this person’s RA is aggressive enough to raise broader health concerns.
Treatment Options
There is no single reliable way to eliminate rheumatoid nodules, and management depends on how much trouble they are causing. Many nodules are left alone if they are painless and not interfering with function. When treatment is pursued, the options range from local injections to systemic drugs to surgery.
Corticosteroid injections directly into the nodule can reduce size and pain. One study of 66 injected nodules found an average 42% reduction in diameter at four months, with all treated nodules becoming less painful and most becoming softer. The downsides were considerable, though: about 70% of injected sites developed skin thinning or color changes, more than half of the nodules came back within a year, and nearly half eventually required surgery anyway.17PubMed Central. Outcomes and Complications of Corticosteroid Injection of Rheumatoid Nodules A smaller study was more optimistic about triamcinolone injections as a surgery alternative, reporting no adverse events, though the limited sample size prevented strong conclusions.18PubMed. Corticosteroid injections reduce size of rheumatoid nodules
Surgical removal is straightforward when a nodule is causing pain, limiting movement, or compressing a nerve. The main drawback is recurrence: nodules often grow back at or near the same site, particularly if the underlying disease remains active. Surgery is usually reserved for situations where the nodule is functionally disabling or has become infected.
On the systemic side, newer targeted therapies offer some promise. A case series of patients whose nodules had resisted multiple prior RA treatments found that JAK inhibitors (a class of drugs that blocks a specific signaling pathway inside immune cells) led to resolution or improvement in all cases. One patient whose nodules had been present the longest did not respond to tofacitinib but saw resolution on upadacitinib, possibly because of its stronger inhibition of the JAK1 pathway.19JAAD Case Reports. Resolution of refractory rheumatoid nodules with Janus kinase inhibitors: A case series This is early evidence from a small number of patients, but it points toward the JAK-STAT pathway as a meaningful driver of nodule biology and suggests these drugs could become an option for stubborn cases.
Imaging Rheumatoid Nodules
When a lump needs evaluation but a biopsy is not yet warranted, ultrasound can provide useful information. Rheumatoid nodules on ultrasound appear as well-defined, relatively homogeneous masses that often sit close to the bone surface without eroding it. Some nodules show a central dark zone that may correspond to the dead collagen core visible on biopsy.20PubMed. Ultrasonography for assessment of subcutaneous nodules This helps distinguish them from other soft-tissue masses, like the tophi seen in gout, which have a different internal structure. Research comparing the immune cell behavior in rheumatoid nodules versus gouty tophi found that nodules show much more active and continuous migration of immune cells toward the necrotic center, while gout tophi recruit their macrophages in a more limited, one-time fashion.21PubMed. Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules
Pseudorheumatoid Nodules in Children
Children can develop firm subcutaneous lumps that look identical to rheumatoid nodules under the microscope but have nothing to do with rheumatoid arthritis. These are called pseudorheumatoid nodules, or deep granuloma annulare, and they are considered benign and not associated with any systemic illness.22JAMA Pediatrics. Benign Rheumatoid Nodules They tend to appear in characteristic locations: the front of the lower legs, the feet, and the scalp, particularly the back of the head. A study of 35 children with these nodules found that about 70% developed additional or recurrent lumps over time, but no predisposing underlying condition was identified in any of them.23PubMed. Deep granuloma annulare (pseudorheumatoid nodule) in children: clinicopathologic study of 35 cases
In a separate series of 20 children, most were boys, and the nodules overwhelmingly arose on the front of the lower leg. Some recurrences were observed, but only one patient had a weakly positive rheumatoid factor, and that child was the only one with a distant recurrence.24PubMed. Pseudorheumatoid nodule (deep granuloma annulare) of childhood: clinicopathologic features of twenty patients The main clinical concern with these nodules is not the lumps themselves but the anxiety they generate. A parent discovering a firm, painless mass on a child’s shin understandably worries about something serious. A biopsy showing the classic palisading granuloma pattern can create further alarm if the pathologist does not specify that pseudorheumatoid nodules in children are a distinct, harmless entity. Recognizing this condition spares families unnecessary testing and lets clinicians reassure them that new bumps, while likely, are expected and not dangerous.